System and method for determining optimal atrioventricular delay based on intrinsic conduction delays

• US 7,248,925 B2
• Filed: 08/27/2004
• Issued: 07/24/2007
• Est. Priority Date: 08/27/2004
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Min, Xiaoyi, Park, Euljoon, Levine, Paul A., Bruhns, Ken
• Primary Examiner(s): Layno; Carl
• Assistant Examiner(s): SARCIONE, JESSICA LYNN
• Application Number:
  US10/928,586
• Publication Number:
  US 20060047319A1
• Time in Patent Office: 1,061 Days
• Field of Search: 607/9, 607 17- 18, 607/25, 607/30, 607/32, 607 59- 60, 600508-509
• US Class Current: 607/25
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/3682 with a variable atrioventricular delay

Abstract

A system and method for estimating optimal atrioventricular delay values for use in pacing the ventricles. Both the intrinsic inter-atrial conduction delay and the intrinsic atrioventricular conduction delay are determined for the patient and then the preferred atrioventricular pacing delay is derived therefrom. By taking into account intrinsic inter-atrial delay along with intrinsic atrioventricular delay, a more reliable estimate of the true optimal atrioventricular delay values for the patient can be achieved than with techniques that only take into account intrinsic atrioventricular delay values. In one example, the technique uses intracardiac electrogram (IEGM) signals and surface electrocardiogram (EKG) signals and hence can be performed by an external programmer without requiring Doppler echocardiography or other cardiac performance monitoring techniques. In another example, wherein the implanted device is equipped with a coronary sinus lead, the technique uses only IEGM signals and hence can be performed by the device itself.

Claims

1. A method for determining an atrioventricular delay value for use in delivering cardiac pacing therapy to a heart of a patient in which an implantable cardiac stimulation device is implanted, the method comprising:

determining an inter-atrial conduction delay for the patient;

determining an intrinsic atrioventricular conduction delay for the patient; and

determining an atrioventricular delay value for use in pacing based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay;

wherein determining the inter-atrial conduction delay for the patient comprises;

determining a width of an electrical atrial event; and

deriving the inter-atrial conduction delay from the width of the atrial event;

wherein determining the width of the atrial event comprises;

inputting an atrial intracardiac electrogram (A-IEGM) signal derived from a lead implanted within the atria of the patient;

inputting a surface electrocardiogram (EKG) signal derived from leads mounted externally on the patient;

determining a value representative of the duration of an atrial event detected within the A-IEGM signal; and

adjusting the value based on a comparison of the A-IEGM signal and the EKG signal.

2. A method for determining an atrioventricular delay value for use in delivering cardiac pacing therapy to a heart of a patient in which an implantable cardiac stimulation device is implanted, the method comprising:

determining an inter-atrial conduction delay for the patient;

determining an intrinsic atrioventricular conduction delay for the patient; and

determining an atrioventricular delay value for use in pacing based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay;

wherein determining the atrioventricular delay value based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay comprises;

determining a first candidate delay value (AS-VP₁) based on the inter-atrial conduction delay in combination with the intrinsic atrioventricular delay derived from sensed atrial events;

determining a second candidate delay value (AS-VP₂) based on the inter-atrial conduction delay derived from sensed atrial events; and

evaluating a AS-VP delay based on a comparison of AS-VP₁ and AS-VP₂.

3. The method of claim 2 further comprising delivering pacing therapy using the implantable cardiac stimulation device subject to the atrioventricular delay value.

4. The method of claim 2 wherein determining the inter-atrial conduction delay for the patient comprises:

determining a width of an electrical atrial event; and

deriving the inter-atrial conduction delay from the width of the atrial event.

5. The method of claim 4 wherein the atrial event is representative of an intrinsic atrial depolarization.

6. The method of claim 2 wherein evaluating the AS-VP delay based on a comparison of AS-VP₁ and AS-VP₂ is performed by selecting the shorter of the AS-VP₁, AS-VP₂ values.

7. The method of claim 2 wherein determining the atrioventricular delay value is performed by the implanted device based on intracardiac electrogram (IEGM) signals.

8. The method of claim 2 further comprising adjusting the atrioventricular delay value based on current patient heart rate.

9. The method of claim 8 wherein adjusting the atrioventricular delay value based on patient heart rate is performed by applying a scaling factor (β

) to a delay value between a sensed atrial event and a subsequent paced ventricular event (AS-VP) wherein the scaling factor is based on current heart rate or a resting heart rate.

10. A method for determining an atrioventricular delay value for use in delivering cardiac pacing therapy to a heart of a patient in which an implantable cardiac stimulation device is implanted, the method comprising:

determining an inter-atrial conduction delay for the patient;

determining an intrinsic atrioventricular conduction delay for the patient; and

determining an atrioventricular delay value for use in pacing based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay;

wherein determining atrioventricular pacing delay values based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay comprises;

determining a first candidate delay value (AP-VP₁) based on the inter-atrial conduction delay in combination with the intrinsic atrioventricular delay derived from paced atrial events;

determining a second candidate delay value (AP-VP₂) based on the inter-atrial conduction delay derived from paced atrial events; and

evaluating a AP-VP delay based on a comparison of AP-VP₁ and AP-VP₂.

11. The method of claim 10 wherein the atrial event is representative of an atrial evoked response.

12. A method for determining an atrioventricular delay value for use in delivering cardiac pacing therapy to a heart of a patient in which an implantable cardiac stimulation device is implanted, the method comprising:

determining an inter-atrial conduction delay for the patient;

determining an intrinsic atrioventricular conduction delay for the patient; and

determining an atrioventricular delay value for use in pacing based on the inter-atrial conduction delay and the intrinsic atrioventricular conduction delay;

wherein determining an inter-atrial conduction delay for the patient comprises detecting the end of at least one atrial event in an atrial intracardiac electrogram (A-IEGM) signal by;

detecting the onset of the atrial event in the A-IEGM signal;

opening a detection window within the A-IEGM signal;

setting positive and negative threshold values;

identifying a last point in time within the detection window at which the A-IEGM signal falls outside the threshold values; and

identifying the last point in time as being the end of the atrial event.